Thursday, 03 April 2025, Virtual
Recording now available
About the webinar
Watch this Rhythm sponsored webinar to learn about the VENTURE trial results from 2 years of age and hear Professor Jesús Argente and Professor Carel Le Roux talk about the importance of early diagnosis and intervention in rare melanocortin-4 receptor (MC4R) pathway diseases.
KEY TOPICS:
During this Rhythm-sponsored webinar, Professor Jesús Argente (Hospital Infantil Universitario Niño Jesús, Madrid) and Professor Carel Le Roux (University College, Dublin) discuss about the VENTURE trial results from 2 years of age and the importance of early diagnosis and intervention in rare melanocortin-4 receptor (MC4R) pathway diseases
Prof Carel Le Roux
Prof Jesús Argente
Please login or signup to unlock the videos.Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.
Prof Carel Le Roux
(Ireland)
Prof Jesús Argente
(Spain)
This webinar is fully organised and funded by Rhythm Pharmaceuticals Netherlands B.V. and is intended for healthcare professionals only. The session will include promotional content on Rhythm products.